Headquartered in Nussloch, Germany, Leica Biosystems is a global leader in advancing cancer diagnostics and workflow solutions. From biopsy to diagnosis, it aims to offer integrated solutions, improved quality, automation, proven performance, and reliable results. Integrating next-generation technology with medicine, Leica has introduced access to digital pathology using AI and Machine Learning.
The Leica Biosystems Companion Diagnostics (CDx) team collaborates with many other leading biotechnology and pharmaceutical companies to develop and commercialize diagnostic test solutions. With the support of the scientific and medical community, Leica’s mission is to identify the challenges faced by pathologists and healthcare providers and subsequently improve cancer diagnosis and patient care for all. This article will review Leica Biosystems’ product portfolio, solutions, and services.
Leica Biosystems has a comprehensive portfolio that spans the entire workflow from biopsy to diagnosis. From general research instruments to tracking and specific workflows, Leica brings industry-leading digital pathology equipment to healthcare professionals worldwide.
Leica’s integrated histology solutions provide workflow automation to facilitate effective sample preparation and timely delivery of slides. Its histology equipment is designed to reduce manual errors and increase patient safety. Leica offers:
Leica’s wide range of plug-and-play consumables has the potential to improve processing quality, cut research time, and reduce manual errors. Leica understands that labs rely on a consistent supply of high-quality consumables; for this reason, it offers:
For advanced staining, Leica Biosystems has introduced automated stainers with rapid and high-quality staining. The technology includes all the BOND systems tailored to meet your lab’s specific diagnostic requirements. Choose from its:
For all pathological diagnoses, IHC primary antibodies optimized for manual and automated applications are available. For molecular pathology, Leica offers a variety of Kreatech FISH probes as well as Novocastra ISH Probes for reliably detecting RNA sequences.
Leica Biosystems has a strong product portfolio that supports digitally-driven discoveries and diagnostics. Leica Biosystems has integrated pathology with AI to get outstanding image quality and optimal results. Apply Leica’s products to optimize the following workflows:
To ease the diagnostic process, Leica Biosystems offers various research and clinical solutions.
Leica Biosystems has collaborated with clinicians to provide end-to-end solutions that facilitate and expedite diagnosis processes. Portfolio solutions for cancer diagnosis include:
To accelerate the process of transforming scientific research into outcomes, Leica Biosystems aims to provide researchers with novel technologies. Product applications in life sciences and research majorly include multiplexing immunochemistry.
With the help of multiplexing, researchers can assess multiple biomarkers at specific locations within a tissue. The latest technologies include multiplex IHC, ISH, and FISH.
Leica Biosystems is committed to supporting precise tissue preparation, IHC, ISH, Emerging tests, and digital pathology.
Portfolio solutions include HistoCore PELORIS 3 Premium Tissue Processing System, Leica TP1020, HistoCore PEGASUS Plus Tissue Processor, and more.
Leica Biosystems provides certified field engineers to service your equipment to minimize error and time-wasting. With this comes priority service, fixed cost of operations, and peak performance.
To avoid in-person visits and customer inconvenience, Leica has trained staff that are ready to answer all your questions. They attend to remote troubleshooting and provide support through email or phone.
For training and monitoring purposes, Leica provides Instructions For Use (IFUs) and decontamination certificates for all products. IFUs in additional languages are supplied in the form of PDF on the CD ROM on your instrument(s). Webinars are also conducted to educate a larger audience.
For more information on Leica’s product portfolio and services, please visit www.leicabiosystems.com.
Bringing innovation, technology, and medical expertise together, Leica Biosystems is working on breakthrough advances in cancer diagnosis. Its products and services range from histological solutions to digital pathology, giving proven performance and excellent user experience.
Procuring instrumentation from leading manufacturers such as Leica requires a huge upfront investment that many labs just aren’t positioned to make. If you have a laboratory or run a research institute that’s tight on budget, consider Excedr’s comprehensive and custom lease program.
We provide hassle-free procurement of high-quality lab equipment with customized solutions according to your needs.
Don’t have the budget to purchase lab equipment outright? Consider leasing through Excedr to save your lab time and money. Browse your leasing options today!
